Mesoblast Ltd Files 6-K with SEC
Ticker: MEOBF · Form: 6-K · Filed: Dec 12, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Dec 12, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, regulatory-update
Related Tickers: MESO
TL;DR
MESO files 6-K, attaching ASX announcement. Stay tuned for details.
AI Summary
On December 12, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. The filing incorporates this announcement by reference, providing an update on the company's activities. Mesoblast Limited is incorporated in Australia and its principal executive offices are located in Melbourne.
Why It Matters
This filing indicates Mesoblast Limited is providing an update to the market and regulators, which could contain material information about its business operations or financial status.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that incorporates a press release, not indicating any immediate negative or positive event.
Key Numbers
- 001-37626 — SEC File Number (Identifies Mesoblast Limited's filings with the SEC.)
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- December 12, 2025 (date) — Filing Date
- Australian Securities Exchange (company) — Exchange where announcement was made
- 001-37626 (other) — SEC File Number
FAQ
What is the specific content of the new release announcement filed as Exhibit 99.1?
The provided text does not detail the content of the new release announcement, only that it was filed with the Australian Securities Exchange and is incorporated by reference into this 6-K filing.
When was the announcement incorporated by reference into the 6-K filing?
The announcement was incorporated by reference into the 6-K filing on December 12, 2025.
What is Mesoblast Limited's jurisdiction of incorporation?
Mesoblast Limited is incorporated in Australia.
Who is the Chief Executive Officer and Executive Director of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
What is the SIC code for Mesoblast Limited?
The Standard Industrial Classification (SIC) code for Mesoblast Limited is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 212 words · 1 min read · ~1 pages · Grade level 17.3 · Accepted 2025-12-11 20:09:01
Filing Documents
- a2025-12x12ryoncilatash.htm (6-K) — 15KB
- exhibit991.htm (EX-99.1) — 9KB
- exhibit991001.jpg (GRAPHIC) — 286KB
- exhibit991002.jpg (GRAPHIC) — 256KB
- 0001345099-25-000107.txt ( ) — 771KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated December 12, 2025 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated December 12, 2025.